[Federal Register Volume 86, Number 122 (Tuesday, June 29, 2021)]
[Notices]
[Page 34247]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13764]



[[Page 34247]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-15-358: Molecular and Cellular Causal Aspects of 
Alzheimer's Disease.
    Date: July 21, 2021.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Adem Can, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD 20892, (301) 435-
1042, <a href="/cdn-cgi/l/email-protection#1073717e7122507363623e7e79783e777f66"><span class="__cf_email__" data-cfemail="c3a0a2ada2f183a0b0b1edadaaabeda4acb5">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Motivated Behavior, Alcohol, and Heavy 
Metal.
    Date: July 21, 2021.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Michael Selmanoff, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5164, MSC 7844, Bethesda, MD 
20892, 301-435-1119, <a href="/cdn-cgi/l/email-protection#ea998f86878b848587aa899998c4848382c48d859c"><span class="__cf_email__" data-cfemail="f083959c9d919e9f9db0938382de9e9998de979f86">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-20-140: Catalytic Tool and Technology Development in 
Kidney, Urologic, and Hematologic Diseases (R21).
    Date: July 21, 2021.
    Time: 1:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Atul Sahai, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 2188, MSC 7818, Bethesda, MD 20892, 301-435-
1198, <a href="/cdn-cgi/l/email-protection#81f2e0e9e0e8e0c1e2f2f3afefe8e9afe6eef7"><span class="__cf_email__" data-cfemail="51223039303830113222237f3f38397f363e27">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Vascular and Blood Cell Pathobiology.
    Date: July 22, 2021.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 
20892, 301-408-9497, <a href="/cdn-cgi/l/email-protection#1c6673697d755c7f6f6e32727574327b736a"><span class="__cf_email__" data-cfemail="116b7e647078517262633f7f78793f767e67">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Neuropharmacology and Signaling.
    Date: July 22, 2021.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Carol Hamelink, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4192, MSC 7850, Bethesda, MD 
20892, (301) 213-9887, <a href="/cdn-cgi/l/email-protection#aec6cfc3cbc2c7c0cdeecddddc80c0c7c680c9c1d8"><span class="__cf_email__" data-cfemail="88e0e9e5ede4e1e6ebc8ebfbfaa6e6e1e0a6efe7fe">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: June 23, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-13764 Filed 6-28-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>